Differences Between Breastfed and Formula Fed Infants

NCT ID: NCT03493711

Last Updated: 2025-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

158 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-21

Study Completion Date

2024-08-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will help us learn how a child's diet affects growth and development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will see how infants diet affects their growth and development. Up to 170 infants will be enrolled for one visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast Fed

Exclusively breastfed for first 3 months of life

No interventions assigned to this group

Milk-based formula fed

Exclusively on Similac Advance Formula for at least 1 month prior to visit

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Exclusive breast feeding or cow milk formula feeding during the first 3 months of life.
* For formula feeders, exclusively on Similac Advance Formula for at least 1 month prior to visit
* Age 2.5-3.5 months

Exclusion Criteria

* Infants born to mother with preexisting medical conditions.
* Infants born to mother with medications during pregnancy known to influence fetal growth.
* Infants born to smoking, alcohol drinking or drug use mothers during pregnancy.
* Preterm
Minimum Eligible Age

2 Months

Maximum Eligible Age

3 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arkansas Children's Hospital Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aline Andres, PhD, RD

Role: PRINCIPAL_INVESTIGATOR

Arkansas Children's Nutrition Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arkansas Children's Nutrition Center

Little Rock, Arkansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

217562

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breastfeeding Study
NCT03387124 COMPLETED
Beginnings Study Follow up
NCT03108014 COMPLETED
Preterm Infants Fed a Human Milk Fortifier
NCT05551975 NOT_YET_RECRUITING NA
Probiotic Formula and Infant Growth
NCT01476397 COMPLETED NA